Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Newormics
Newormics is a developer of the first high-throughput, high-content drug screening platforms for use with in vivo small animal models as well as in vitro 3D tissue constructs. The company provides…
Newormics
Newormics is a developer of the first high-throughput, high-content drug screening platforms for use with in vivo small animal models as well as in vitro 3D tissue constructs. The company provides…
TL;DR
Founded: 2016
Industry: Biotechnology (microfluidics, drug screening, toxicology)
Product: Microfluidics-based high-throughput, high-content drug screening platforms (in vivo small animal and in vitro 3D tissue constructs)
Employees (approx.): 12
Company Overview
Problem Domain
Early-stage drug discovery and toxicology testing—improving throughput, content, and cost-efficiency of assays.
Founded
2016
Industry
Biotechnology
Funding Track Record
Last funding date reported as 2018-02-21; investor listing includes MassChallenge.
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week